Anthropometric and central obesity indices as predictors of long-term cardiometabolic risk among Saudi young and middle-aged men and women

Mahmoud M A Abulmeaty, Ali M Almajwal, Najwa K Almadani, Mona S Aldosari, Ahmed A Alnajim, Saeed B Ali, Heba M Hassan, Hany A Elkatawy, Mahmoud M A Abulmeaty, Ali M Almajwal, Najwa K Almadani, Mona S Aldosari, Ahmed A Alnajim, Saeed B Ali, Heba M Hassan, Hany A Elkatawy

Abstract

To investigate the prediction of long-term cardiometabolic risk using anthropometric and central obesity parameters. Methods: A total of 390 Saudi subjects (men 42.8%) aged 18-50 years were enrolled in a cross-sectional study in King Saud University, Riyadh, Kingdom of Saudi Arabia between August 2014 and January 2016. All participants were instructed to fast for 12 hours before taking blood samples for glucose and lipid panel analyses. A full anthropometric measurement and bioelectric impedance analysis was performed. The anthropometric and central obesity parameters were used for correlation with 30-year Framingham and life-time American College of Cardiology/American Heart Association risk scores. We used receiver operator characteristic curves to select the best predictors with the highest sensitivity and specificity. Results: The best discriminators of the long-term cardiometabolic risk among all the studied variables in men were the visceral adiposity index (VAI) (AUC=0.767), conicity index (CI) (AUC=0.817), and mid-arm muscular area (MAMA) (AUC=0.639). The best predictors for women were body mass index (AUC=0.912), waist circumference (AUC=0.752), and lipid accumulation product (AUC=0.632). The Kappa coefficient and 95% confidence interval ranged from 0.1 to 0.35, which suggests that there is a poor to fair agreement between these indices and cardiovascular risk scores. Conclusion: Long-term cardiometabolic risk can be predicted using simple anthropometric and central obesity indices, and these discriminators were not the same in Saudi men and women.

References

    1. Martin MY, Francis LA. U.S. Migrant networks and adult cardiometabolic health in El Salvador. J Immigr Minor Health. 2016;18:1350–1356.
    1. Masson M, Siniawski D, Krauss J, Cagide A. Clinical Applicability of the Framingham 30-Year Risk Score. Usefulness in Cardiovascular Risk Stratification and the Diagnosis of Carotid Atherosclerotic Plaque. Rev Esp Cardiol. 2011;64:305–331.
    1. Redon J. Global Cardiovascular Risk Assessment: Strengths and Limitations. High Blood Press Cardiovasc Prev. 2016;23:87–90.
    1. Guerra-Silva NM, Santucci FS, Moreira RC, Massao Tashima C, de Melo SC, Pereira LR, et al. Coronary disease risk assessment in men: Comparison between ASCVD Risk versus Framingham. Int J Cardiol. 2016;228:481–487.
    1. Morawiec R, Janikowski K, Lelonek M. Thirty-year risk of cardiovascular disease in senior medical students - based on the StudHeart study. Kardiochir Torakochirurgia Pol. 2016;13:172–177.
    1. Goff DC, Jr, Lloyd-Jones DM, Bennett G, Coady S, D'Agostino RB, Gibbons R, et al. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines [published correction appears in Circulation. Circulation. 2014;129(25 suppl 2):S49–S73.
    1. de Rooij BH, van der Berg JD, van der Kallen CJ, Schram MT, Savelberg HH, Schaper NC, et al. Physical Activity and Sedentary Behavior in Metabolically Healthy versus Unhealthy Obese and Non-Obese Individuals - The Maastricht Study. PLoS One. 2016;11:e0154358.
    1. Roriz AK, Passos LC, de Oliveira CC, Eickemberg M, Moreira PA, Sampaio LR. Evaluation of the accuracy of anthropometric clinical indicators of visceral fat in adults and elderly. PLoS One. 2014;9:e103499.
    1. Zeng Q, Dong S, Sun X, Xie J, Cui Y. Percent body fat is a better predictor of cardiovascular risk factors than body mass index. Braz J Med Biol Res. 2012;45:591–600.
    1. Teo BW, Toh QC, Chan XW, Xu H, Li JL, Lee EJ. Assessment of muscle mass and its association with protein intake in a multi-ethnic Asian population: relevance in chronic kidney disease. Asia Pac J Clin Nutr. 2014;23:619–625.
    1. Lira Santos A, Araújo Tavares de Sá CM, Calado Brito D, Lourenço Batista C, Kétteryn Maior Evangelista da Costa M, Araújo Gomes de Lima KB, et al. Accuracy parameters as indicators of anthropometric adiposity visceral scheduled for two-dimensional equation. Nutr Hosp. 2015;32:2046–2053.
    1. Ezeukwu AO, Agwubike EO. Anthropometric measures of adiposity as correlates of atherogenic index of plasma in non-obese sedentary Nigerian males. Libyan J Med. 2014;9:23798.
    1. Whitehead SJ, Ford C, Gama R. A combined laboratory and field evaluation of the Cholestech LDX and CardioChek PA point-of-care testing lipid and glucose analyzers. Ann of Clin Biochem. 2013;0:1–14.
    1. Ferreira CE, França CN, Correr CJ, Zucker ML, Andriolo A, Scartezini M. Clinical correlation between a point-of-care testing system and laboratory automation for lipid profile. Clin Chim Acta. 2015;446:263–269.
    1. Guo SX, Zhang XH, Zhang JY, He J, Yan YZ, Ma JL, et al. Visceral Adiposity and Anthropometric Indicators as Screening Tools of Metabolic Syndrome among Low Income Rural Adults in Xinjiang. Sci Rep. 2016;6:36091.
    1. Chiang J, Koo M. Lipid accumulation product: a simple and accurate index for predicting metabolic syndrome in Taiwanese people aged 50 and over. BMC Cardiovascular Disorders. 2012;12:78.
    1. Abulmeaty MMA, Almajwal AM, Hassan HM. New cutoff values for fat mass index, fat-free mass index and percent body fat in overweight and obese men living in Riyadh, SA. Int J Diabetes Dev Ctries. 2015;36:204–212.
    1. Kones R, Rumana U. Cardiovascular Prevention: Components, Levels, Early Origins, and Metrics. Hospital Practice. 2014;42:84–95.
    1. Al-Ajlan A. Lipid Profile in Relation to Anthropometric Measurements among College Male Students in Riyadh, Saudi Arabia: A Cross-Sectional Study. Int J Biomed Sci. 2011;7:112–119.
    1. Gharakhanlou R, Farzad B, Agha-Alinejad H, Steffen LM, Bayati M. Anthropometric measures as predictors of cardiovascular disease risk factors in the urban population of Iran. Arq Bras Cardiol. 2012;98:126–134.
    1. Vásquez FD, Corvalán CL, Uauy RE, Kain JA. Anthropometric indicators as predictors of total body fat and cardiometabolic risk factors in Chilean children at 4, 7 and 10 years of age. Eur J Clin Nutr. 2016:9. [Epub ahead of print]
    1. Saeed AA, Al-Hamdan NA. Anthropometric risk factors and predictors of hypertension among Saudi adult population –A national survey. J Epidemiol Glob Health. 2013;3:197–204.
    1. Shidfar F, Alborzi F, Salehi M, Nnojomi M. Association of waist circumference, body mass index and conicity index with cardiovascular risk factors in postmenopausal women. Cardiovasc J Afr. 2012;23:442–445.
    1. Oh JY, Sung YA, Lee HJ. The visceral adiposity index as a predictor of insulin resistance in young women with polycystic ovary syndrome. Obesity (Silver Spring) 2013;21:1690–1694.
    1. de-Oliveira PM, da Silva FA, Oliveira RMS, Mendes LL, Netto MP, Cândido APC. Association between fat mass index and fat-free mass index values and cardiovascular risk in adolescents. Rev Paul Pediatr. 2016;34:30–37.
    1. Vieira BA, Sauer P, Marcadenti A, Piovesan CH. Association between LAP Index (Lipid Accumulation Product) and metabolic profile in hospitalized patients. Nutr Hosp. 2015;31:2771–2774.
    1. Gowda V, Philip KM. Abdominal volume index and conicity index in predicting metabolic abnormalities in young women of different socioeconomic class. Int J Med Sci Public Health. 2016;5:1452–1456.
    1. Ehsani B, Moslehi N, Mirmiran P, Tehrani FR, Tahmasebinejad Z, Azizi F. A visceral adiposity index-related dietary pattern and the cardiometabolic profiles in women with polycystic ovary syndrome. Clin Nutr. 2016;35:1181–1187.
    1. Oh JY, Sung YA, Lee HJ. Lipid accumulation product as a useful index for identifying abnormal glucose regulation in young Korean women. Diabet Med. 2013;30:436–442.
    1. Goh LGH, Dhaliwal SS, Welborn TA, Lee AH, Della PR. Anthropometric measurements of general and central obesity and the prediction of cardiovascular disease risk in women: a cross-sectional study. BMJ Open. 2014;4:e004138.
    1. de Oliveira ACM, Ferreira RC, Santos AA. Cardiovascular risk assessment according to the Framingham score and abdominal obesity in individuals seen by a clinical school of nutrition. Rev Assoc Med Bras. 2016;62:138–144.
    1. Fauziana R, Jeyagurunathan A, Abdin E, Vaingankar J, Sagayadevan V, Shafie S, et al. Body mass index, waist-hip ratio and risk of chronic medical condition in the elderly population: results from the Well-being of the Singapore Elderly (WiSE) Study. BMC Geriatrics. 2016;16:125–134.
    1. Costa EC, Ferezini de Sá JC, Soares EMM, Moura-Lemos TMA, Maranhão TMD, Azevedo GD. Anthropometric indices of central obesity how discriminators of metabolic syndrome in Brazilian women with polycystic ovary syndrome. Gynecol Endocrinol. 2012;28:12–15.
    1. Amato MC, Giordano C, Pitrone M, Galluzzo A. Cut-off points of the visceral adiposity index (VAI) identifying a visceral adipose dysfunction associated with cardiometabolic risk in a Caucasian Sicilian population. Lipids Health Dis. 2011;10:183.
    1. Motamed N, Perumal D, Fhea M, Zamani F, Ashrafi H, Haghjoo M, et al. Conicity Index and Waist-to-Hip Ratio Are Superior Obesity Indices in Predicting 10-Year Cardiovascular Risk Among Men and Women. Clin Cardiol. 2015;38:527–534.
    1. Hosseinpanah F, Barzin M, Mirbolouk M, Abtahi H, Cheraghi L, Azizi F. Lipid accumulation product and incident cardiovascular events in a normal weight population: Tehran Lipid and Glucose Study. Eur J Prev Cardiol. 2016;23:187–193.
    1. Velija-Asimi Z, Burekovic A, Dujic T, Dizdarevic-Bostandzic A, Semiz S. Incidence of prediabetes and risk of developing cardiovascular disease in women with polycystic ovary syndrome. Bosn J Basic Med Sci. 2016;16:298–306.
    1. McHugh ML. Interrater reliability: the kappa statistic. Biochem Med (Zagreb) 2012;22:276–282.
    1. Dantas EMD, Pinto CJ, Freitas RPD, de Medeiros ACQ. Agreement in cardiovascular risk rating based on anthropometric parameters. Einstein (Sao Paulo) 2015;13:376–80.

Source: PubMed

Спонсоры и соавторы

Заболевания

Медикаментозные вмешательства

Подписаться